Hansoh Pharmaceutical (03692) Announces January 2026 Monthly Return and Convertible Bonds Maturity

Bulletin Express02-03 17:26

Hansoh Pharmaceutical Group Company Limited (stock code: 03692) reported that its authorized share capital remained unchanged at 20,000,000,000 ordinary shares with a par value of HKD 0.00001 each, totaling HKD 200,000. The number of issued shares was 6,055,150,070 with no treasury shares, showing no change compared to the previous month. The public float requirement of 16.21% was met as of the end of January 2026.

The zero coupon convertible bonds due 2026 with an outstanding principal amount of USD 5,378,000 matured during the period. The bonds carried a subscription/conversion price of HKD 56.7 and were listed under stock code 40546. No new shares were issued pursuant to the maturity of these convertibles, and no other issuance or repurchase activities were recorded.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1116348419?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-03 17:26","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1116348419","market":"hk","top_or_hot":-1,"title":"Hansoh Pharmaceutical (03692) Announces January 2026 Monthly Return and Convertible Bonds Maturity","media":"Bulletin Express","content":"<p>Hansoh Pharmaceutical Group Company Limited (stock code: 03692) reported that its authorized share capital remained unchanged at 20,000,000,000 ordinary shares with a par value of HKD 0.00001 each, totaling HKD 200,000. The number of issued shares was 6,055,150,070 with no treasury shares, showing no change compared to the previous month. The public float requirement of 16.21% was met as of the end of January 2026.</p>\n<p>The zero coupon convertible bonds due 2026 with an outstanding principal amount of USD 5,378,000 matured during the period. The bonds carried a subscription/conversion price of HKD 56.7 and were listed under stock code 40546. No new shares were issued pursuant to the maturity of these convertibles, and no other issuance or repurchase activities were recorded.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Hansoh Pharmaceutical (03692) Announces January 2026 Monthly Return and Convertible Bonds Maturity</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHansoh Pharmaceutical (03692) Announces January 2026 Monthly Return and Convertible Bonds Maturity\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-02-03 17:26</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Hansoh Pharmaceutical Group Company Limited (stock code: 03692) reported that its authorized share capital remained unchanged at 20,000,000,000 ordinary shares with a par value of HKD 0.00001 each, totaling HKD 200,000. The number of issued shares was 6,055,150,070 with no treasury shares, showing no change compared to the previous month. The public float requirement of 16.21% was met as of the end of January 2026.</p>\n<p>The zero coupon convertible bonds due 2026 with an outstanding principal amount of USD 5,378,000 matured during the period. The bonds carried a subscription/conversion price of HKD 56.7 and were listed under stock code 40546. No new shares were issued pursuant to the maturity of these convertibles, and no other issuance or repurchase activities were recorded.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"03692","symbol_name":"翰森制药","start_time":0,"source_url":"","article_id":"1116348419","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1116348419","pubTimestamp":1770110818,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Hansoh Pharmaceutical Group Company Limited (stock code: 03692) reported that its authorized share capital remained unchanged at 20,000,000,000 ordinary shares with a par value of HKD 0.00001 each,...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"03692":"翰森制药"},"translate_title":"豪森药业(03692)公布2026年1月月报表及可换股债券到期","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"03692":1},"content_text":"Hansoh Pharmaceutical Group Company Limited (stock code: 03692) reported that its authorized share capital remained unchanged at 20,000,000,000 ordinary shares with a par value of HKD 0.00001 each, totaling HKD 200,000. The number of issued shares was 6,055,150,070 with no treasury shares, showing no change compared to the previous month. The public float requirement of 16.21% was met as of the end of January 2026.\nThe zero coupon convertible bonds due 2026 with an outstanding principal amount of USD 5,378,000 matured during the period. The bonds carried a subscription/conversion price of HKD 56.7 and were listed under stock code 40546. No new shares were issued pursuant to the maturity of these convertibles, and no other issuance or repurchase activities were recorded.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"dataReport,SGX","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1116348419","isCrawlerRequest":true}